Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced HBV-Related Hepatocellular Carcinoma (HCC)”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)UnknownNCT03236636
What this trial is testing

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Who this might be right for
Advanced HBV-Related Hepatocellular Carcinoma (HCC)
Beijing Shenogen Biomedical Co., Ltd 312
Early research (Phase 1)UnknownNCT05738447
What this trial is testing

Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
West China Hospital 9
Early research (Phase 1)UnknownNCT04032392
What this trial is testing

Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 20
Early research (Phase 1)Looking for participantsNCT07557251
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma

Who this might be right for
Advanced HBV-Related Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 21
Early research (Phase 1)UnknownNCT05339321
What this trial is testing

Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 36
Not applicableLooking for participantsNCT07769827
What this trial is testing

Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC

Who this might be right for
HBV-HCCUnresectable Advanced HBV-related Liver Cancer
Jinling Hospital, China 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294
What this trial is testing

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma
Lion TCR Pte. Ltd. 55
Post-approval studies (Phase 4)Study completedNCT07084948
What this trial is testing

Inhibition of HBV Replication and Biological Reversal of Cirrhosis (F3-F4) and HCC by Flavonoids

Who this might be right for
Hepatitis B Virus Infection
Trieu, Nguyen Thi, M.D. 134